Jingyang Wang

Jingyang Wang is from Greater Boston. Jingyang works in the following industries: "Biotechnology Research". Jingyang is currently Sr. Director, Analytical Development at Atea Pharmaceuticals, Inc, located in Boston, Massachusetts, United States. In Jingyang's previous role as a Director at Atea Pharmaceuticals, Inc, Jingyang worked in Boston, Massachusetts, United States until Aug 2021. Prior to joining Atea Pharmaceuticals, Inc, Jingyang was a Associate Director, Analytical Development (Small Molecules) at GSK and held the position of Associate Director, Analytical Development (Small Molecules) at Waltham, Massachusetts, United States. Prior to that, Jingyang was a Senior Manager, Analytical Development, Small Molecules at TESARO, Inc., based in Waltham, Massachusetts, United States from Jun 2016 to Dec 2019. Jingyang started working as CMC Analytical at Boston Biomedical, Inc. in Cambridge, MA in Jul 2015. From Mar 2012 to Dec 2014, Jingyang was Principal Scientist, CMC at Idenix Pharmaceuticals - (Acquired by Merck & Co, Aug 2014), based in Cambridge, MA. Prior to that, Jingyang was a Senior Scientist at Idenix Pharmaceuticals - (Acquired by Merck & Co, Aug 2014), based in Cambridge, MA from Jun 2010 to Mar 2012. Jingyang started working as Scientist II/I at Idenix Pharmaceuticals - (Acquired by Merck & Co, Aug 2014) in Cambridge, MA in May 2004.